Skip to main content
Mycodern Spolka Akcyjna logo

Mycodern Spolka Akcyjna — Investor Relations & Filings

Ticker · MCD ISIN · PLMDNPL00013 LEI · 25940087YXP4K8ENAO45 WAR Manufacturing
Open in API
Filings indexed 54 across all filing types
Latest filing 2023-11-29 Share Issue/Capital Cha…
Country PL Poland
Listing WAR MCD

About Mycodern Spolka Akcyjna

https://mycodern.pl/

Mycodern Spolka Akcyjna is a producer of functional foods and innovative dietary supplements. The company's product portfolio includes items such as functional gummies and oils. Its business activities encompass contract manufacturing, wholesale, trading, and retail distribution.

Recent filings

Filing Released Lang Actions
Publikacja ogłoszenia o ofercie objęcia akcji serii E przez akcjonariuszy posiadających prawa poboru - zmiana terminu przyjmowania zapisów na akcje serii E - Content (PL)
Share Issue/Capital Change Classification · 95% confidence The document text, written in Polish, discusses an extension of the deadline for subscribing to Series E shares related to a rights offering ('prawo poboru'). It explicitly mentions that the 'dokument informacyjny o ofercie papierów wartościowych' (information document on the securities offering) has been updated and is attached to the current report ('niniejszego raportu'). This structure—announcing an update/extension to a financing event and attaching the revised core document—is characteristic of a Capital/Financing Update (CAP). While it involves an offering document, the primary action reported is the change in the subscription timeline for capital raising, making CAP the most appropriate classification over a general Regulatory Filing (RNS) or a specific Share Issue (SHA), as it details the process and timeline of the financing activity.
2023-11-29 Polish
Formularz zapisu - seria E
Share Issue/Capital Change Classification · 99% confidence The document is titled "FORMULARZ ZAPISU NA AKCJE ZWYKŁE NA OKAZICIELA SERII E MYCODERN SPÓŁKA AKCYJNA" which translates to 'SUBSCRIPTION FORM FOR SERIES E BEARER COMMON SHARES OF MYCODERN S.A.'. It contains detailed fields for a subscriber to apply for shares, specifying the number of shares, subscription price (0.65 PLN), payment method, and legal declarations related to the subscription process. This clearly indicates a document related to a capital raising or share issuance activity. Based on the definitions, this fits best under 'Capital/Financing Update' (CAP), as it is the actual instrument used to subscribe to new shares being offered, which is a core financing activity. It is not a general announcement (RPA/RNS), nor is it a report (10-K, IR, ER).
2023-10-23 Polish
Dokument Ofertowy - seria E
Capital/Financing Update Classification · 98% confidence The document is titled "Dokument informacyjny o ofercie papierów wartościowych" (Information Document on the Offering of Securities) and explicitly states it was prepared to meet requirements of the Polish Act on Public Offering (art. 37a). It details the offering of Series E shares, including the subscription process, intended use of proceeds, and extensive risk factors related to the offering and the company's operations. This structure—a comprehensive document detailing a specific capital raising event (share offering) and associated risks—is characteristic of a prospectus or offering circular. In the context of the provided definitions, this is a document related to financing activities and capital structure changes, fitting best under 'Capital/Financing Update' (CAP), as it is the primary document detailing the terms of the capital raise, rather than just a brief announcement (RPA/RNS).
2023-10-23 Polish
Publikacja ogłoszenia o ofercie objęcia akcji serii E przez akcjonariuszy posiadających prawa poboru - Content (PL)
Capital/Financing Update Classification · 98% confidence The document text, written in Polish, discusses the execution of a rights issue (prawo poboru) for Series E shares, detailing the subscription process, ratios (10 rights per 1 share), and deadlines (13.11.2023). It explicitly mentions that the company is providing the subscription form template ('wzór formularza zapisu') and an information document ('dokument informacyjny') required under Polish public offering law. Since the core subject is the announcement of the terms and procedure for a capital increase/share offering, this falls under 'Capital/Financing Update' (CAP). Although it includes attachments (the form/document), the primary purpose is the announcement of the financing terms, not just the publication of a report (RPA) or a general regulatory filing (RNS).
2023-10-23 Polish
Zawarcie ramowej umowy w zakresie wytwarzania i dostawy żelków - Content (PL)
Regulatory Filings Classification · 95% confidence The document is a formal announcement by the Management Board ('Zarząd') of Mycodern S.A. regarding the conclusion of a significant agreement (a contract for the exclusive production of sugar-free gummies for a Partner). The text explicitly states that the Management Board considered this information 'material' ('istotną') due to its potential impact on the company's financial results and brand recognition. This content—announcing a significant business contract or strategic development—does not fit neatly into standard financial reports (10-K, IR, ER) or specific corporate actions (DIV, SHA, DIRS). It is a general, material business update. Given the options, this type of announcement, which details a significant operational agreement and its potential financial impact, is best classified as a general Regulatory Filing (RNS) as it is a mandatory disclosure of material non-public information in the Polish market context, or potentially a general business update not covered by the more specific categories. Since RNS is the designated fallback for miscellaneous regulatory announcements that don't fit elsewhere, it is the most appropriate choice here, as it is a formal disclosure of a material event.
2023-10-12 Polish
Strategia i prezentacja Grupy Kapitałowej Mycodern S.A.
Investor Presentation Classification · 98% confidence The document is titled "Strategia i prezentacja Grupy Kapitałowej Mycodern S.A." (Strategy and Presentation of the Mycodern S.A. Capital Group). It outlines the company's strategy for the next two years, covering production capabilities, investment plans (including seeking a strategic partner and capital increase), future innovations (soft lozenges), and future vision (market expansion). The structure, content (agenda, market analysis, investment needs, future plans), and presentation format strongly indicate this is an Investor Presentation (IP) designed to communicate strategic direction and funding needs to potential investors or stakeholders, rather than a formal regulatory filing like a 10-K or an Earnings Release (ER).
2023-10-06 Polish

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.